Skip to main content
Figure 8 | BMC Cancer

Figure 8

From: Parallel screening of FDA-approved antineoplastic drugs for identifying sensitizers of TRAIL-induced apoptosis in cancer cells

Figure 8

Evaluation of treatments in non-malignant cell line. Mitoxantrone (a) and mithramycin (b) in HPDE6 human pancreatic duct epithelial cells. Single-agent treatments are shown as "dark grey diamonds" and combination treatments with 10 ng/mL of TRAIL are shown as "light grey squares". Data are presented on a logarithmic scale and the lines connecting data points are for visualization only.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us